Yongkang Yang

5PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 06, 2026
Targeting conserved domains of hypoxia-inducible factors for cancer therapy.

Shaima Salman, Tina Y Huang, Yousang Hwang

|Dec 12, 2025
HIF-1-mediated ISG20 expression promotes breast cancer stemness and immune evasion.

Yongkang Yang, Qiaozhu Zuo, Vijay Ramu

|Mar 14, 2025
QRICH1 mediates an intracellular checkpoint for CD8+ T cell activation via the CARD11 signalosome.

Nicole M Carter, Wihib D Hankore, Yong-Kang Yang

|Aug 28, 2024
Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy.

Walter Jackson Iii, Yongkang Yang, Shaima Salman

|Dec 09, 2022
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification.

Yongkang Yang, Chelsey Chen, Qiaozhu Zuo

Pageof 1

Frequent Collaborators

4 joint publications

Gregg L Semenza

4 joint publications

Yajing Lyu

4 joint publications

Shaima Salman

3 joint publications

Dominic Dordai